
Johnson & Johnson: The Bull Case Can No Longer Be Ignored (NYSE:JNJ)
yuelan I last updated investors in Johnson & Johnson, or J&J (NYSE:JNJ), in early April, urging them to capitalize on its capitulation to add more shares. That thesis has worked out well, as JNJ dip buyers held its March lows ($150 level), lifting buying sentiments. Following its remarkable surge into its early August highs ($176…